![](/img/cover-not-exists.png)
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study
Mansour, Sam E, Kiernan, Daniel F, Roth, Daniel B, Eichenbaum, David, Holekamp, Nancy M, Kaba, Samer, Werts, EricaJournal:
British Journal of Ophthalmology
DOI:
10.1136/bjophthalmol-2020-315984
Date:
May, 2020
File:
PDF, 491 KB
2020